醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
IRD · Opus Genetics, Inc.
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Opus Genetics, Inc.（IRD）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $3.0M；高管董事有效買入 —、有效賣出 $2.8M。最近申報 2026-10-02。
買入 Bought—
賣出 Sold$3.0M
有效買入 Effective bought—
有效賣出 Effective sold$2.8M
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-09-30 | Foundation Fighting Blindness Retinal Degeneration Fund Director, Other | 賣出 Sell · 有效 | 556,000 | $4.96 | $2.8M | SEC |
| 2026-09-03 | Gagnon Robert E. Chief Financial Officer | 賣出 Sell | 28,000 | $4.54 | $127K | SEC |
| 2026-07-23 | Gagnon Robert E. Chief Financial Officer | 賣出 Sell | 7,783 | $2.95 | $23K | SEC |
| 2026-07-23 | Magrath George Chief Executive Officer, Director | 賣出 Sell | 9,475 | $2.95 | $28K | SEC |
| 2026-07-23 | SCHACHLE JOSEPH K Chief Operating Officer | 賣出 Sell | 4,644 | $2.94 | $14K | SEC |
| 2026-07-23 | YERXA BENJAMIN R Director, President | 賣出 Sell | 7,429 | $2.97 | $22K | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-09-03 | Gagnon Robert E. Officer | 28,000 | $125K | 10b5-1 |
| 2026-07-23 | Magrath George Officer | 9,475 | $29K | |
| 2026-07-23 | Gagnon Robert E. Officer | 7,783 | $24K | |
| 2026-07-23 | YERXA BENJAMIN R Officer | 7,429 | $22K | |
| 2026-07-23 | SCHACHLE JOSEPH K Officer | 4,644 | $14K |
內部人 Insiders
Foundation Fighting Blindness Retinal Degeneration Fund、Gagnon Robert E.、Magrath George、SCHACHLE JOSEPH K、YERXA BENJAMIN R